RECRUITING

Voice-Activated Technology to Improve Mobility & Reduce Health Disparities (EngAGE)

Talk to us

Conditions

Frailty

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.

Official Title

Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing Frail, Multimorbid and Homebound Older Adult-Care Partner Dyads

Quick Facts

Study Start:2022-10-26
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05337514

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age greater than or equal to 65 years
  2. * has at least 2 chronic conditions
  3. * requires any assistance to leave the home (this may include requiring someone to drive, requiring the use of a cane or walker, or similar)
  4. * can read 14 point font from a 2-foot distance on a tablet-sized screen
  5. * can hear spoken voice from 2-foot distance
  6. * SPPB score of less than or equal to 9 but greater than 3 on a 12-point scale to target moderate but not severe functional impairment.
  1. * reported history of moderate to advanced cognitive impairment;
  2. * inability to stand unassisted;
  3. * inability to understand English (because the intervention is currently only available in English);
  4. * life expectancy less than 12 months or enrolled in Hospice;
  5. * a medical condition making unsupervised physical activity potentially unsafe including: stroke within prior 12 months, acute myocardial infarction or unstable angina in the prior 6 months, uncontrolled arrhythmias, dissecting aortic aneurysm, acute endo/pericarditis, acute thromboembolism, acute or severe heart or respiratory failure, uncontrolled hypertension greater than 180/100, fracture or joint replacement within the prior 3 months, infections affecting one's general health condition, severe peripheral vascular disease.
  6. * severe functional impairment as indicated by an SPPB score less than 3 (out of 12);
  7. * baseline Montreal Cognitive Assessment of less than or equal to 18/30;
  8. * inability to understand consent (teach back).

Contacts and Locations

Study Contact

Melanie Norstrom, PhD
CONTACT
(984) 689-2992
mnorstrom@medicine.bsd.uchicago.edu
Megan Huisingh-Scheetz, MD
CONTACT
(773) 702-8311
Megan.Huisingh-Scheetz@uchospitals.edu

Principal Investigator

Megan Huisingh-Scheetz, MD
PRINCIPAL_INVESTIGATOR
University of Chicago

Study Locations (Sites)

University of Chicago
Chicago, Illinois, 60637
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Megan Huisingh-Scheetz, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-26
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2022-10-26
Study Completion Date2026-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Frailty